Nouvelles de la Bourse

Dernières actualités financières · Mis à jour Jul 13, 2026

NVDA AMD
▬ mixed

BofA voit Nvidia à 350 $ alors que l'IA agentique entraîne un cycle de puces « sans précédent »

BofA’s Vivek Arya Sees Nvidia at $350 as Agentic AI Drives an “Unprecedented” Chip Cycle

The panelists debate the sustainability of NVIDIA's growth and margins, with concerns around execution risks, China revenue volatility, competition, and …

Yahoo Finance · Mai 26, 2026
EXE
▬ mixed

Les analystes de Wall Street prédisent-ils une hausse ou une baisse de l'action Expand Energy ?

Are Wall Street Analysts Predicting Expand Energy Stock Will Climb or Sink?

The panelists generally agree that EXE's recent performance and future prospects are concerning, with the stock underperforming peers despite a …

Yahoo Finance · Mai 26, 2026
ATO
▬ mixed

Wall Street est-il haussier ou baissier sur l'action Atmos Energy ?

Is Wall Street Bullish or Bearish on Atmos Energy Stock?

Despite solid EPS growth and raised guidance, Atmos Energy's (ATO) stock faces headwinds due to regulatory risks, particularly capex inflation …

Yahoo Finance · Mai 26, 2026
MRVL
▬ mixed

Voici combien le titre Marvell devrait bouger après les résultats

Here's How Much Marvell Stock Is Expected to Move After Earnings

The panel's net takeaway is that Marvell's current price reflects high optimism, with significant risks around customer concentration, margin compression, …

Yahoo Finance · Mai 26, 2026
PODD
▼ bear…

Les analystes de Wall Street sont-ils optimistes sur l'action Insulet ?

Are Wall Street Analysts Bullish on Insulet Stock?

The panel is bearish on PODD, citing GLP-1 competition, reimbursement risks, and potential margin compression from international expansion.

Yahoo Finance · Mai 26, 2026
UHS
▬ mixed

Les analystes de Wall Street apprécient-ils l'action Universal Health Services ?

Do Wall Street Analysts Like Universal Health Services Stock?

The panel's net takeaway is that UHS's recent underperformance and high valuation are concerning, with significant risks from labor costs, …

Yahoo Finance · Mai 26, 2026
AVB
▼ bear…

Les analystes de Wall Street aiment-ils l'action AvalonBay Communities ?

Do Wall Street Analysts Like AvalonBay Communities Stock?

The panel consensus is bearish on AvalonBay (AVB), citing structural headwinds in high-end multifamily demand, repeated revenue and AFFO misses, …

Yahoo Finance · Mai 26, 2026
▬ mixed

SpaceX est une « fournaise à argent », déclare un ancien gestionnaire de hedge fund alors qu'un dépôt révèle une perte trimestrielle de 4,3 milliards de dollars

SpaceX Is A 'Money Furnace,' Former Hedge Fund Manager Says As Filing Reveals $4.3 Billion Quarterly Loss

The panel consensus is bearish on SpaceX's IPO, citing high burn rates, unproven orbital economics, and potential stranded asset risks …

Yahoo Finance · Mai 26, 2026
CINF
▬ mixed

Cincinnati Financial Actions : Estimations et notations des analystes

Cincinnati Financial Stock: Analyst Estimates & Ratings

Despite solid Q1 EPS and revenue growth, panelists express concern about CINF's exposure to rising catastrophe losses, claims inflation, and …

Yahoo Finance · Mai 26, 2026
VOYA
▬ mixed

Voya Financial Augmente ses Bénéfices dans ses 3 Segments d'Activité

Voya Financial Grows Earnings Across All 3 Business Segments

The panel has a mixed view on Voya, with concerns about interest rate sensitivity, earnings volatility, and anemic retirement net …

Yahoo Finance · Mai 26, 2026
RBLX GME
▬ mixed

Roblox contre GameStop : Quelle action de jeu acheter en 2026 ?

Roblox vs. GameStop: Which Gaming Stock Is a Better Buy in 2026?

The panelists generally agree that while Roblox (RBLX) has impressive growth, its high debt-to-equity ratio, heavy stock-based compensation, and platform …

Nasdaq · Mai 26, 2026
JNJ
▬ mixed

Les politiques de prix des médicaments du président Trump pourraient nuire aux bénéfices des fabricants de médicaments. Est-il temps de vendre des actions pharmaceutiques ?

President Trump's Drug Pricing Policies Could Hurt Drugmakers' Profits. Time to Sell Pharma Stocks?

The panel consensus is bearish, with key risks including accelerated pipeline prioritization towards non-US markets due to MFN, potential margin …

Nasdaq · Mai 26, 2026